Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors (clinicaltrials.gov) - Sep 30, 2026 - P=N/A | N=195 | Completed | Sponsor: University Health Network, Toronto | Active, not recruiting ➔ Completed
Trial completion • Neuroendocrine Tumor • Oncology • Solid Tumor
|